Sandoz, Germany, is a 120-year-old company and is the generic pharmaceuticals division of Novartis. The company is the main provider of TB drugs to the World Health Organization. Sandoz is also part of Novartis' Global TB Alliance for TB Drug Development.

Reliance Life Sciences, India, opened the Reliance TB and HIV Control Center in Gujarat, India, in May 2004. The center has provided counseling to 4,615 patients and provided Directly Observed Treatment Short-course therapy to 97 patients from Asian countries.

Takeda, Japan, the largest pharmaceutical company in Japan, launched the Takeda Initiative on March 18, 2010. The program is designed to support the Global Fund to fight AIDS, tuberculosis and malaria.

Eisai, Japan, is working with other European and American drugmakers and research institutions to develop vaccines for diseases such as tuberculosis and hepatitis.

Sanofi-Aventis, launched a transformation program in 2009 to make R&D an innovation driver operating in a new environment. The firm has implemented the TB Free Program among others. The group aims to help raise awareness about the disease, the importance of diagnosis as soon as the first symptoms appear, and support for TB patients.